Editorial for: "Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging".
BOUTRY, Sébastien; LAURENT, Sophie; BURTEA, Carmen
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
BOUTRY, Sébastien ; Université de Mons - UMONS > Faculté de Médecine et de Pharmac > Service du Doyen de la Faculté de Médecine et Pharmacie ; Center for Microscopy and Molecular Imaging, Charleroi, Belgium
LAURENT, Sophie ; Université de Mons - UMONS > Faculté de Médecine et de Pharmac > Service de Chimie générale, organique et biomédicale ; Center for Microscopy and Molecular Imaging, Charleroi, Belgium
BURTEA, Carmen ; Université de Mons - UMONS > Faculté de Médecine et de Pharmac > Service de Chimie générale, organique et biomédicale
Language :
English
Title :
Editorial for: "Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging".
O'Connor JPB, Rose CJ, Waterton JC, Carano RAD, Parker GJM, Jackson A. Imaging intratumor heterogeneity: Role in therapy response, resistance, and clinical outcome. Clin Cancer 2015;21(2):249-257. https://doi.org/10.1158/1078-0432.CCR-14-0990.
Just N. Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 2014;111:2205-2213. https://doi.org/10.1038/bjc.2014.512.
Pope WB, Kim HJ, Huo J, et al. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment radiology. Radiology 2009;252(1):182-189. https://doi.org/10.1148/radiol.2521081534.
Gao Y, Wang Q, Zhang L, et al. Treatment response assessment in multiple myeloma: Histogram analysis of total tumor apparent diffusion coefficient based on whole-body diffusion-weighted MR imaging. J Magn Reson Imaging 2023. https://doi.org/10.1002/jmri.29155.
Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reason Imaging 2010;32(1):2-16. https://doi.org/10.1002/jmri.22167.
Dutoit JC. Verstraete KL MRI in multiple myeloma: A pictorial review of diagnostic and post-treatment findings. Insights Imaging 2016;7:553-569. https://doi.org/10.1007/s13244-016-0492-7.
Padhani AR, van Ree K, Collins DJ, D'Sa S, Makris A. Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. AJR 2013;200:163-170. https://doi.org/10.2214/AJR.11.8185.
Treitl KM, Ricke J, Baur-Melnyk A. Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging. Skeletal Radiol 2022;51:43-58. https://doi.org/10.1007/s00256-021-03799-4.
Koutoulidis V, Terpos E, Papanikolaou N, et al. Comparison of MRI features of fat fraction and ADC for early treatment response assessment in participants with multiple myeloma. Radiology 2022;304(1):137-144. https://doi.org/10.1148/radiol.211388.
